02.03.14
Health Canada has issued an NPN for Brattleboro, VT-based NutraGenesis’ flagship ingredient Sensoril (NPN 80047814). This new product license issuance allows Sensoril to be sold throughout Canada.
“We are very pleased that our Sensoril ingredient is available for Canadian dietary supplement marketers to formulate with”, says Suzanne McNeary, co-founder and president of NutraGenesis. “We believe that the compelling claims that were afforded in the product license will be very attractive to the Canadian marketplace,”she added. NutraGenesis engaged their long term Canadian consulting firm NHP Consulting, Inc. to work on the NPN for Sensoril.
The claims include “Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate”, “Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress” and “Helps support cardiovascular health”.
Multi-patented Sensoril is supported by seven human clinical trials and is manufactured by NutraGenesis partner Natreon, Inc. of New Brunswick, NJ.
“We are very pleased that our Sensoril ingredient is available for Canadian dietary supplement marketers to formulate with”, says Suzanne McNeary, co-founder and president of NutraGenesis. “We believe that the compelling claims that were afforded in the product license will be very attractive to the Canadian marketplace,”she added. NutraGenesis engaged their long term Canadian consulting firm NHP Consulting, Inc. to work on the NPN for Sensoril.
The claims include “Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate”, “Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress” and “Helps support cardiovascular health”.
Multi-patented Sensoril is supported by seven human clinical trials and is manufactured by NutraGenesis partner Natreon, Inc. of New Brunswick, NJ.
